July 2012
Washington, DC —Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued a statement today in response to the decision by the Federal Housing Finance Agency to forbid Fannie Mae and Freddie Mac from reducing principal on mortgages even though such modifications would prevent larger losses resulting from foreclosures.
Washington, DC – Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, will offer brief remarks regarding executive compensation at for-profit colleges at a press conference hosted by Senator Tom Harkin, Chairman of the Senate Health, Education, Labor and Pensions Committee.
Sen. Harkin will unveil a report on for-profit education, and the 30 companies that have been the focus of a two-year investigation by his Committee.
Washington, DC—Today, Rep. Elijah E. Cummings, the Ranking Member of the Committee on Oversight and Government Reform, circulated a memo with preliminary findings from his investigation of executive pay at for-profit educational institutions—which receive a majority of their funds from U.S. taxpayers in the form of financial aid to students.
Washington, DC—Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued a statement today in response to an announcement by the Department of Justice and the Office of the Comptroller of the Currency of a settlement requiring Capital One Bank to pay approximately $12 million in damages to servicemembers for violating the Servicemembers Civil Relief Act (SCRA).
Washington, DC—Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, released a report titled "Shining Light on the Gray Market," which exposed a network of private "gray market" companies that take advantage of the national drug shortage crisis to charge exorbitant prices for drugs used to treat cancer and other life-threatening conditions.
Washington, DC - Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement regarding the House of Representatives' passage of a continuing resolution that delays the Affordable Care Act by one year and repeals the Medical Device Tax:
Washington, D.C.—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, applauded House passage of H.R. 3204, Drug Quality and Security Act, a bipartisan, bicameral bill that will improve consumer
drug safety.
Washington, DC—Today, Rep. Elijah E.